Improved cardiac T1 reactivity measures for gadolinium-free MRI assessment of ischemic heart disease
改进心脏 T1 反应性测量,用于缺血性心脏病的无钆 MRI 评估
基本信息
- 批准号:10705358
- 负责人:
- 金额:$ 48.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-23 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmericanAmerican Heart AssociationAngiographyBiological MarkersBlood VolumeBlood flowBody partBrainBreathingCardiacCardiovascular DiseasesCatheterizationCause of DeathChronic Kidney FailureContrast MediaCoronary ArteriosclerosisDepositionDetectionDiseaseEventFinancial compensationFutureGadoliniumGlomerular Filtration RateGoldHealthcareHeartHeart DiseasesHeart RateImageInferiorInstitutionIonizing radiationKidney DiseasesLiteratureLongitudinal StudiesMagnetic Resonance ImagingMapsMeasuresMethodsMotionMulticenter StudiesMyocardialMyocardial IschemiaMyocardial perfusionMyocardial tissueMyocardiumPatient TriagePatientsPerformancePerfusionPharmacologyPhaseProtocols documentationRadialRecoveryRenal functionReportingResolutionRestRiskScanningSensitivity and SpecificitySliceSpeedStressTechniquesTechnologyTestingTimeTreatment EfficacyVariantbasecardiac magnetic resonance imagingcostdata acquisitiondeep learningexperienceimage registrationimaging modalityimprovednovelpatient populationperfusion imagingrapid techniquereconstructionsingle photon emission computed tomographystress statesuccesstoolvalidation studies
项目摘要
Summary: Ischemic heart disease (IHD), also called coronary artery disease, is a major healthcare problem
that affects over 20 million Americans and costs our nation an estimated $82.8 billion each year. Myocardial
perfusion imaging is a proven tool to detect and characterize IHD. While Single Photon Emission Computed
Tomography (SPECT) imaging is widely used in the U.S., MRI offers higher resolution perfusion images
without ionizing radiation. However, perfusion MRI requires injecting gadolinium-based contrast agents to
identify regions of perfusion deficit. Gadolinium is problematic in patients with poor kidney function, who are
excluded from these cardiac MR perfusion studies. Cardiac T1 mapping recently has shown promise to
identify and characterize coronary artery disease without the use of gadolinium. T1 mapping is performed in a
pharmacologically induced stress state and again in the resting state of the heart to compute T1 differences as
a percentage known as T1 reactivity. By reflecting blood volume changes, T1 reactivity has shown to be
promising to identify ischemic regions in the myocardium. T1 reactivity is a promising biomarker not only for
triaging patients for catheterization but also in longitudinal studies to determine the efficacy of therapy and to
predict future cardiac events. However, existing protocols are sub-optimal to reliably detect T1 changes at
stress. It is also difficult for patients to hold their breath for long durations at stress and inadequate motion
compensation leads to poor T1 map quality. The limited time window of pharmacological stress can limit the
slice coverage. In order to fully evaluate the potential of the non-contrast T1 approach, we plan to develop a
robust T1 mapping method that optimizes the T1 mapping protocol, by developing a robust motion
compensation method and obtaining whole heart coverage within the limited time window and significantly
reduce the breath-hold duration. Specific aims of the project are (1) to optimize T1 mapping protocol and
develop a robust image registration method for large breathing motion at stress (2) to develop novel
simultaneous multi-slice acquisition methods and state-of-the-art deep learning techniques for rapid, whole-
heart T1 mapping, and (3) to validate the new rapid T1 mapping by comparing it to the current gadolinium-
based perfusion method for IHD detection. Our team and institution have deep cardiac MRI experience and the
technology needed to successfully execute all aspects of this project. The success of our project will deliver a
game-changing MRI technology for patients with suspected IHD: rapid, whole-heart coverage T1 mapping
without the use of gadolinium, and validation studies that accurately characterize the performance of the new
method.
缺血性心脏病(IHD),也称为冠状动脉疾病,是一个主要的医疗保健问题
这影响了2000多万美国人,每年给我们国家造成的损失估计为828亿美元。心肌
灌注成像是检测和表征IHD的经验证的工具。计算单光子发射时
断层扫描(SPECT)成像在美国被广泛使用,MRI提供更高分辨率的灌注图像
没有电离辐射。然而,灌注MRI需要注射基于钆的造影剂,
识别灌注不足区域。钆在肾功能不佳的患者中是有问题的,
从这些心脏MR灌注研究中排除。心脏T1标测最近显示出希望,
在不使用钆的情况下识别和表征冠状动脉疾病。T1映射在
在心脏的静息状态下再次计算T1差异,
这一百分比被称为T1反应性。通过反映血容量的变化,T1反应性已被证明是
有望识别心肌中的缺血区域。T1反应性是一种有前途的生物标志物,不仅适用于
分类患者进行导管插入术,但也进行纵向研究,以确定治疗的有效性,
预测未来的心脏事件。然而,现有的协议是次优的,以可靠地检测T1变化,
应力患者在压力和运动不足的情况下也很难长时间屏住呼吸
补偿导致差的T1图质量。药理学应激的有限时间窗可以限制
切片覆盖率。为了充分评估非造影剂T1方法的潜力,我们计划开发一种
稳健的T1标测方法,通过开发稳健的运动来优化T1标测协议
补偿方法,并在有限的时间窗口内获得整个心脏覆盖,
减少屏气时间。本项目的具体目标是:(1)优化T1映射协议,
开发一种用于压力下大呼吸运动的鲁棒图像配准方法(2),以开发新的
同步多切片采集方法和最先进的深度学习技术,
心脏T1标测,以及(3)通过将新的快速T1标测与当前的钆-
基于灌注的IHD检测方法。我们的团队和机构拥有深厚的心脏MRI经验,
成功执行该项目的各个方面所需的技术。我们项目的成功将带来一个
用于疑似IHD患者的改变游戏规则的MRI技术:快速,全心脏覆盖的T1标测
不使用钆,以及准确表征新产品性能的验证研究
法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ganesh Adluru其他文献
Ganesh Adluru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ganesh Adluru', 18)}}的其他基金
Improved Estimation of Ischemic Burden with Cardiac MRI
使用心脏 MRI 改进缺血负担的估计
- 批准号:
9367063 - 财政年份:2017
- 资助金额:
$ 48.93万 - 项目类别:
相似海外基金
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348998 - 财政年份:2025
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348999 - 财政年份:2025
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
- 批准号:
2412294 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
- 批准号:
2415059 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Conference: Polymeric Materials: Science and Engineering Division Centennial Celebration at the Spring 2024 American Chemical Society Meeting
会议:高分子材料:美国化学会 2024 年春季会议科学与工程部百年庆典
- 批准号:
2415569 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346565 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346564 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
- 批准号:
2401164 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
- 批准号:
2333724 - 财政年份:2024
- 资助金额:
$ 48.93万 - 项目类别:
Standard Grant